Perinatal Infections Market to Grow with a CAGR of 5.25% through 2029
Rising prevalence of
perinatal infections and growing healthcare expenditure are factors driving the
Global Perinatal Infections Market in the forecast period 2025-2029
According to
TechSci Research report, “Perinatal Infections Market – Global Industry
Size, Share, Trends, Competition Forecast & Opportunities, 2029”,
the Global Perinatal Infections Market stood at USD 1.52 billion in 2023 and is
anticipated to grow with a CAGR of 5.25% in the forecast period, 2025-2029. The global market for perinatal infections is witnessing substantial growth, propelled by several key factors such as heightened awareness, increased healthcare spending, technological advancements, and population growth. Perinatal infections pose significant challenges worldwide, driving the demand for advanced diagnostic and therapeutic solutions. These infections, occurring during pregnancy, childbirth, and the immediate postpartum period, carry serious risks for both mothers and newborns. With a rising global prevalence of perinatal infections, there's a growing need for improved diagnostic and treatment options. This uptrend has spurred the expansion of the perinatal infections market as healthcare providers and governments intensify efforts to prevent and manage these infections.
Browse
over XX market data Figures spread through XX Pages and an in-depth TOC on
"Global Perinatal Infections Market”
Public awareness regarding perinatal infections has significantly increased, owing to government initiatives, educational campaigns, and improved access to healthcare information. Healthcare professionals are actively advocating for prenatal and perinatal screening to detect infections early, leading to a higher demand for diagnostic tools and tests. This heightened awareness has contributed to the expansion of the perinatal infections market.
Technological advancements in the healthcare sector have revolutionized the diagnosis and treatment of perinatal infections. Advanced diagnostic techniques, such as PCR-based tests and next-generation sequencing, have enhanced the accuracy and efficiency of infection detection. Moreover, these technologies have facilitated the development of targeted therapies and preventive measures. As technology continues to advance, it is expected to play a crucial role in driving further growth in the perinatal infections market.
The Global Perinatal
Infections Market is segmented into Infection Type, treatment, diagnosis, end
user and company.
Based on end users, the Hospitals & Clinics segment has emerged as the dominant market leader. These healthcare facilities offer a comprehensive array of treatment options, including antibiotics, antiviral medications, and supportive care, for both mothers and newborns affected by perinatal infections. Moreover, hospitals and clinics possess the necessary infrastructure to provide intensive care services for critically ill newborns, ensuring optimal chances of recovery.
Based on Region, the North America segment is projected to witness growth during the forecast period. The healthcare sector in this region has actively promoted awareness regarding perinatal infections, highlighting the significance of early diagnosis and treatment. This heightened awareness has led to an increased number of expectant mothers seeking medical attention, thereby contributing to market growth. Additionally, governments in North America have implemented various initiatives aimed at promoting maternal and child health, such as screening programs, vaccination campaigns, and educational initiatives, all of which positively impact the perinatal infections market.
Also, the Asia Pacific region is experiencing rapid market expansion. Asia Pacific serves as a focal point for medical research and innovation, with considerable investments in research and development. These investments have facilitated the development of advanced diagnostic tests and treatment modalities for perinatal infections, further driving market growth in the region.
Major companies
operating in Global Perinatal Infections Market are:
·
Merck KGaA
·
Beckman Coulter Inc.
·
Bio-Rad Laboratories, Inc
·
Hologic Inc.
·
Gilead Sciences, Inc.
·
Emcure Pharmaceuticals Limited.
·
Cipla Inc.
·
Bausch Health Companies Inc
·
Johnson & Johnson
·
Teva Pharmaceutical Industries Ltd.
Download Free Sample Report
Customers can
also request 10% free customization on this report
“The
global perinatal infections market is on an upward trajectory, driven by various
market drivers such as the rising prevalence of perinatal infections,
increasing awareness, technological advancements, growing healthcare
expenditure, expanding global population, and supportive government policies.
As healthcare providers, researchers, and companies work together to develop
better diagnostic and therapeutic solutions, the market for perinatal infection
management is expected to continue its growth in the coming years, improving
the health and well-being of mothers and newborns around the world.” said Mr.
Karan Chechi, Research Director with TechSci Research, a research-based
management consulting firm.
“Perinatal Infections Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Infection Type (Cytomegalovirus Infection, Enterovirus Infection, Genital Herpes, Gonorrhoea, Human Immunodeficiency Virus, Listeriosis Lymphocytic Choriomeningitis Virus, Rubella, Syphilis, Varicella, Others), By Treatment (Antibiotics, Antiviral, Antiretroviral, Others), By Diagnosis (Maternal Test, Neonatal Test, Others), By End user (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region and Competition, 2019-2029F”,
has evaluated the future growth potential of Global Perinatal Infections Market
and provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Perinatal Infections Market.
Contact
TechSci Research
LLC
420 Lexington
Avenue, Suite 300,
New York, United
States- 10170
Tel:
+1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com